Merck & Co. Inc. buy UBS Group AG
Start price
20.10.23
/
50%
€94.60
Target price
20.10.24
€115.24
Performance (%)
30.24%
Price
18:05
€121.80
Summary
This prediction is currently active. With a performance of 30.24% the BUY prediction by UBS_Group_AG is a big success. Dividends of €1.41 are taken into consideration when calculating the performance. This prediction currently runs until 20.10.24. The prediction end date can be changed by UBS_Group_AG at any time. UBS_Group_AG has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m |
---|---|---|
Merck & Co. Inc. | 3.723% | 3.723% |
iShares Core DAX® | 2.594% | -1.861% |
iShares Nasdaq 100 | 3.553% | -2.064% |
iShares Nikkei 225® | 0.687% | -8.704% |
iShares S&P 500 | 2.209% | -1.988% |
Comments by UBS_Group_AG for this prediction
In the thread Merck & Co. Inc. diskutieren
Merck & Co., Inc. (NYSE: MRK) was upgraded by analysts at UBS Group AG from a "neutral" rating to a "buy" rating. They now have a $122.00 price target on the stock, up previously from $117.00.
Ratings data for MRK provided by MarketBeat